SynBioBeta Speaker
Tasuku Kitada
Co-founder, President
Strand Therapeutics
May 2026, SynBioBeta
Speaker
Tasuku Kitada, Ph.D., MBA, is the Co-Founder, Board Director, President, and Head of R&D at Strand Therapeutics, a Boston-based clinical-stage biotechnology company developing programmable mRNA medicines for cancer and autoimmune diseases. He oversees the development of Strand’s Signal Stack platform, which applies computational design principles to enable tissue-selective and precisely controlled therapeutic protein expression using AmpliScript self-replicating RNA and EverScript circular RNA technologies.Dr. Kitada’s work increasingly focuses on the integration of artificial intelligence and computation with synthetic biology, including the use of data-driven models to design, optimize, and predict the behavior of complex RNA regulatory systems and therapeutic payloads. Prior to co-founding Strand, he was a biotech investment analyst at Candriam Investors Group, a global asset management company based in Brussels.He holds a B.S. in Biophysics and Biochemistry from the University of Tokyo, a Ph.D. in Molecular Biology from UCLA, and conducted postdoctoral research at MIT’s Synthetic Biology Center. He also holds an MBA from the Wharton School of the University of Pennsylvania.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Previous Speakers Include
Join for the latest
SynBioBeta event updates.